Ejnmmi Research

Ejnmmi Research

恩米研究

  • 3区 中科院分区
  • Q1 JCR分区

期刊简介

《Ejnmmi Research》是由Springer Berlin Heidelberg出版社于2011年创办的英文国际期刊(ISSN: 2191-219X,E-ISSN: 2191-219X),该期刊长期致力于核医学领域的创新研究,主要研究方向为RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING&nb。作为SCIE收录期刊(JCR分区 Q1,中科院 3区),本刊采用OA开放获取模式(OA占比1%),以发表核医学领域等方向的原创性研究为核心(研究类文章占比95.19%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在104篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Ejnmmi Research审稿周期约为 13 Weeks 。该刊近年未被列入国际预警名单,年发文量约104篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 104 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学
3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学
3区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING SCIE Q1 49 / 204

76.2%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING SCIE Q2 56 / 204

72.79%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:5.9 SJR:0.916 SNIP:0.948
学科类别 分区 排名 百分位
大类:Medicine 小类:Radiology, Nuclear Medicine and Imaging Q1 72 / 333

78%

期刊发文

  • CMR validation of left ventricular volumes and ejection fraction measured by the IQ-SPECT system in patients with small heart size

    Author: Wei, Hua; Wu, Jiaojiao; Han, Ke; Hu, Guang; Wang, Hongliang; Guo, Xiaoshan; Liu, Haiyan; Wu, Zhifang; Li, Sijin

    Journal: EJNMMI RESEARCH. 2023; Vol. 13, Issue 1, pp. -. DOI: 10.1186/s13550-023-00987-2

  • Predicting PD-L1 expression status in patients with non-small cell lung cancer using [F-18]FDG PET/CT radiomics

    Author: Zhao, Xiaoqian; Zhao, Yan; Zhang, Jingmian; Zhang, Zhaoqi; Liu, Lihua; Zhao, Xinming

    Journal: EJNMMI RESEARCH. 2023; Vol. 13, Issue 1, pp. -. DOI: 10.1186/s13550-023-00956-9

  • Direct reconstruction for simultaneous dual-tracer PET imaging based on multi-task learning

    Author: Zeng, Fuzhen; Fang, Jingwan; Muhashi, Amanjule; Liu, Huafeng

    Journal: EJNMMI RESEARCH. 2023; Vol. 13, Issue 1, pp. -. DOI: 10.1186/s13550-023-00955-w

  • The potential application of MR-derived ADCmin values from Ga-68-DOTATATE and F-18-FDG dual tracer PET/MR as replacements for FDG PET in assessment of grade and stage of pancreatic neuroendocrine tumors

    Author: Gao, Jing; Xu, Si; Ju, Huijun; Pan, Yu; Zhang, Yifan

    Journal: EJNMMI RESEARCH. 2023; Vol. 13, Issue 1, pp. -. DOI: 10.1186/s13550-023-00960-z

  • Prognostic value of F-18-FDG PET/CT-based radiomics combining dosiomics and dose volume histogram for head and neck cancer

    Author: Wang, Bingzhen; Liu, Jinghua; Zhang, Xiaolei; Wang, Zhongxiao; Cao, Zhendong; Lu, Lijun; Lv, Wenbing; Wang, Aihui; Li, Shuyan; Wu, Xiaotian; Dong, Xianling

    Journal: EJNMMI RESEARCH. 2023; Vol. 13, Issue 1, pp. -. DOI: 10.1186/s13550-023-00959-6

  • Peptide-based PET imaging agent of tumor TIGIT expression

    Author: Weng, Dinghu; Guo, Rong; Zhu, Ziyang; Gao, Yu; An, Rui; Zhou, Xiuman

    Journal: EJNMMI RESEARCH. 2023; Vol. 13, Issue 1, pp. -. DOI: 10.1186/s13550-023-00982-7

  • Molecular imaging of fibroblast activation in multiple non-ischemic cardiomyopathies

    Author: Wang, Jingnan; Huo, Li; Lin, Xue; Fang, Ligang; Hacker, Marcus; Niu, Na; Li, Xiang

    Journal: EJNMMI RESEARCH. 2023; Vol. 13, Issue 1, pp. -. DOI: 10.1186/s13550-023-00986-3

  • Identification of EGFR mutation status in male patients with non-small-cell lung cancer: role of F-18-FDG PET/CT and serum tumor markers CYFRA21-1 and SCC-Ag

    Author: Jiang, Maoqing; Chen, Ping; Guo, Xiuyu; Zhang, Xiaohui; Gao, Qiaoling; Zhang, Jingfeng; Zhao, Guofang; Zheng, Jianjun

    Journal: EJNMMI RESEARCH. 2023; Vol. 13, Issue 1, pp. -. DOI: 10.1186/s13550-023-00976-5